GlassScriptPhysician profile
Daniel Wagner
NPI 1750348314
$4,015.11
in general payments reported to CMS, 2019-2025
21 companies · $1,217 in 2025
The $1,217 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,360 · 2020: $31.07 · 2021: $148 · 2022: $352 · 2023: $398 · 2024: $509 · 2025: $1,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,123.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,115.14 | 2019-2024 | Mako |
| Ferring Pharmaceuticals INC. | $434.91 | 2019-2025 | Euflexxa |
| Shalby Advanced Technologies, INC. | $340.06 | 2025 | Consensus Hip System, Consensus Knee System, Cks - Vitalite |
| Zimmer Biomet Holdings, INC. | $296.61 | 2019-2022 | |
| Davol INC. | $256.53 | 2025 | Surgiphor |
| Heraeus Medical, LLC. | $247.43 | 2019-2025 | Palacos |
| Depuy Synthes Sales INC. | $182.13 | 2019-2025 | Monovisc |
| Intellijoint Surgical INC. | $174.49 | 2024 | Intellijoint |
| Smith+Nephew, INC. | $156.58 | 2019-2022 | |
| Abbott Laboratories | $137.59 | 2025 | Proclaim |
| Pacira Therapeutics, INC. | $128.39 | 2019-2020 | |
| Heron Therapeutics, INC. | $128.05 | 2022-2025 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $106.40 | 2023 | Iovera |
| Ethicon US, LLC | $74.87 | 2019-2025 | Vistaseal |
| Bioventus LLC | $57.16 | 2023-2024 | Durolane, Durolane |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $48.52 | 2024 | Irrisept |
| Spinal Simplicity, LLC | $39.87 | 2025 | Ha Minuteman G3-R |
| Fidia Pharma USA INC. | $36.51 | 2019-2024 | Hymovis, Triluron, Hyalgan |
| Pylant Medical | $26.61 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $14.97 | 2024 | Caldolor |
| Radius Health, INC. | $12.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.